Prestige Consumer Healthcare PBH Ratios & Valuation
| FY'26 | FY'25 | FY'24 | FY'23 | ||
|---|---|---|---|---|---|
| Profitability | |||||
| Gross margin | 54.7%-1.1pp | 55.8%+0.3pp | 55.5%0.0pp | 55.4%-1.7pp | |
| Operating margin | 28.4%-1.2pp | 29.6%-0.8pp | 30.4%+32.4pp | -2%-32.3pp | |
| Net margin | 17.5%-1.4pp | 18.9%+0.3pp | 18.6%+25.9pp | -7.3%-26.2pp | |
| Returns | |||||
| Return on equity | 10.2%-2.1pp | 12.3%-1.2pp | 13.5%+18.9pp | -5.4%-19.4pp | |
| Return on invested capital | 10.9%-1.2pp | 12.2%-0.3pp | 12.4%+13.2pp | -0.8%-9.5pp | |
| Efficiency | |||||
| Asset turnover | 0.3×0.0× | 0.3×0.0× | 0.3×0.0× | 0.3×0.0× | |
| Liquidity | |||||
| Current ratio | 3.6×-0.6× | 4.2×+1.0× | 3.2×+0.8× | 2.4×+0.4× | |
| Leverage | |||||
| Debt-to-equity | 0.6×0.0× | 0.6×-0.1× | 0.7×-0.3× | 0.9×0.0× | |
| Net debt / EBITDA | 2.9×+0.3× | 2.6×-0.4× | 3×-125× | 128.4×+124× | |
| Per Share | |||||
| Book value per share | $38.74+5.7% | $36.64+11.1% | $32.98+13.7% | $29.01-6.5% | |
| Valuation | |||||
| Market capitalization | $2.8B-34.1% | $4.26B+18.0% | $3.61B+15.8% | $3.12B+17.3% | |
| Price / earnings | 14.7×-5.1× | 19.8×+2.6× | 17.2×— | —— | |
| Price / sales | 2.6×-1.2× | 3.7×+0.5× | 3.2×+0.4× | 2.8×+0.3× | |
| Price / book | 1.5×-0.8× | 2.3×+0.1× | 2.2×0.0× | 2.2×+0.5× | |
| EV / EBITDA | 11.1×-3.1× | 14.2×+1.6× | 12.6×-421× | 433.7×+422× |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Prestige Consumer Healthcare's profit margins?
- Prestige Consumer Healthcare (PBH) runs a 54.7% gross margin and a 28.4% operating margin, with a 17.5% net margin.
- Where do Prestige Consumer Healthcare's ratios come from?
- Every ratio is computed from Prestige Consumer Healthcare's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
